Search results
Results from the WOW.Com Content Network
Hepatitis B vaccine is a vaccine that prevents hepatitis B. [13] The first dose is recommended within 24 hours of birth with either two or three more doses given after that. [ 13 ] This includes those with poor immune function such as from HIV/AIDS and those born premature . [ 13 ]
Dengue vaccine is a vaccine used to prevent dengue fever in humans. [9] Development of dengue vaccines began in the 1920s but was hindered by the need to create immunity against all four dengue serotypes. [10] As of 2023, there are two commercially available vaccines, sold under the brand names Dengvaxia and Qdenga. [11] [12]
CDC Vaccine Information Statement for MMR Vaccine from April 2012. According to the 1993 amended National Childhood Vaccine Injury Act (NCVIA), a VIS must contain at least the following four components: (1) a description of the benefits of the given vaccine, (2) a description of its risks, (3) information about the National Vaccine Injury Compensation Program (VICP), and (4) other relevant ...
In May 2024, TAK-003 became the second dengue vaccine to be prequalified by the World Health Organization (WHO). [51] This live-attenuated vaccine, developed by Takeda is similar to the Dengvaxia vaccine in the fact that it contains a weakened version of the four variants of dengue virus. The difference between the two vaccines is the TAK-003 ...
This includes babies of mothers with hepatitis B, sexual partners, healthcare workers, police and fire workers, and morticians. [6] It provides a temporarily induced immunity by the transfer of immunoglobulins. [citation needed] HBIG is given by either intramuscular (IM) or intravenous (IV) route, depending on the preparation. Side effects ...
There have been more than twice as many cases of dengue fever across North, South and Central America — more than 9.7 million — in the first half of 2024 than there were in all of 2023, the ...
“A serogroup B meningococcal (MenB) vaccine series may be administered to adolescents and young adults 16 through 23 years of age to provide short term protection against most strains of serogroup B meningococcal disease. The preferred age for MenB vaccination is 16 through 18 years of age. (Category B)” [6] The motion was passed, 14 to 1.
That's twice as many as in all of 2023 (4.6 million cases), according to the CDC. Dengue fever infections have skyrocketed as many nations have reported increasingly hot temperatures, ...